Literature DB >> 1668120

IgA immune aggregates stimulate platelet-activating factor and superoxide anion production by human neutrophils. A comparison with IgG aggregates.

P Hernando1, J Egido, R de Nicolas, E Gonzalez.   

Abstract

We have examined the possibility that human polymorphonuclear cells exposed to IgA immune complexes can mediate the production of platelet-activating factor (PAF) and oxygen radicals. We found that human IgA and IgG immune aggregates stimulated, to a similar extent, PAF and O2- production by human polymorphonuclear cells (PMN) in a concentration and time dependent manner. The PAF, that was largely associated with cells, was shown to be identical to synthetic PAF, as determined by physicochemical, chromatographic and enzymatic assay. Furthermore, de novo synthesis of PAF by PMN was shown to occur by incorporation of radioactive precursors, such as [3H]acetate. The addition of normal human serum to PMN incubated with IgG aggregates resulted in a significant amount of PAF formation which was not observed with IgA aggregates. By contrast, no change was seen in PMN O2- with either aggregates. The preincubation of PMN with cytochalasin B, an inhibitor of phagocytosis, did not affect PAF and O2- production by both aggregates. The results suggest that the interaction of PMN with the IgA complexes in blood vessel walls of different tissues can result in the release of lipid mediators, such as PAF and oxygen radicals that could contribute to the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1668120     DOI: 10.1007/bf02536538

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  23 in total

1.  Structural analysis of purified platelet-activating factor by lipases.

Authors:  J Benveniste; J P Le Couedic; J Polonsky; M Tence
Journal:  Nature       Date:  1977-09-08       Impact factor: 49.962

2.  Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent.

Authors:  B M Babior; R S Kipnes; J T Curnutte
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. Correlation of synthesis with release, functional events, and leukotriene B4 metabolism.

Authors:  J H Sisson; S M Prescott; T M McIntyre; G A Zimmerman
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

5.  Acute lung injury in rat caused by immunoglobulin A immune complexes.

Authors:  K J Johnson; B S Wilson; G O Till; P A Ward
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

6.  Activation of the alternative pathway of complement by human serum IgA.

Authors:  P S Hiemstra; A Gorter; M E Stuurman; L A Van Es; M R Daha
Journal:  Eur J Immunol       Date:  1987-03       Impact factor: 5.532

7.  Complement activation in experimental IgA nephropathy: an antigen-mediated process.

Authors:  A Rifai; A Chen; H Imai
Journal:  Kidney Int       Date:  1987-12       Impact factor: 10.612

8.  Handling of soluble IgA aggregates by the mononuclear phagocytic system in mice. A comparison with IgG aggregates.

Authors:  J Egido; J Sancho; F Rivera; M Sanchez-Crespo
Journal:  Immunology       Date:  1982-05       Impact factor: 7.397

Review 9.  Physiological and pathological aspects of circulating immune complexes.

Authors:  J A Schifferli; R P Taylor
Journal:  Kidney Int       Date:  1989-04       Impact factor: 10.612

10.  Activation and desensitization of platelets by platelet-activating factor (PAF) derived from IgE-sensitized basophils. I. Characteristics of the secretory response.

Authors:  P M Henson
Journal:  J Exp Med       Date:  1976-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.